Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm

Abstract

Even though conventional botulinum neurotoxin (BoNT) products have shown successful treatment results in patients with benign blepharospasm (BEB), the main, potential long-term side effect of BoNT use is the development of immunologic resistance due to the production of neutralizing antibody to the neurotoxin after repeated injections. Xeomin… (More)
DOI: 10.2147/OPTH.S13978

Topics

4 Figures and Tables